» Articles » PMID: 1673073

Mechanisms Underlying the Differential Sensitivity to Alpha 1-adrenoceptor Activation in the Bisected Rat Vas Deferens

Overview
Journal Br J Pharmacol
Publisher Wiley
Specialty Pharmacology
Date 1991 Feb 1
PMID 1673073
Citations 7
Authors
Affiliations
Soon will be listed here.
Abstract

1. The factors underlying the different responsiveness of the prostatic and epididymal portions of rat vas deferens to alpha 1-adrenoceptor stimulation were investigated. 2. The alpha 1-adrenoceptors in membranes of both halves of rat vas deferens were labelled with [3H]-prazosin and the affinities of agonists and antagonists for these receptors were determined. In saturation studies, the Bmax and KD values for [3H]-prazosin in membranes of both portions were the same. 3. In competition studies, the inhibition curves for phentolamine were biphasic and consistent with the presence of both alpha 1a- and alpha 1b-adrenoceptor subtypes. The proportions of binding sites with high and low affinity for phentolamine in both halves of rat vas deferens were similar and in good agreement with the percentages of binding sites for WB-4101 and phentolamine previously reported in the whole rat vas deferens. 4. The phenylethylamines displaced [3H]-prazosin with a shallow inhibition curve. The data are compatible with the assumption of two affinity states for the binding sites. For the imidazoline compounds no such distinct affinity states could be demonstrated. 5. The affinity for, and the relative intrinsic efficacy on postsynaptic alpha 1-adrenoceptors of both portions of rat vas deferens were studied for noradrenaline, phenylephrine and methoxamine by irreversible inactivation of the alpha 1-adrenoceptors by phenoxybenzamine. The parameters for partial agonists were determined by comparing the responses to the partial agonist to those of a full agonist in the same tissue. Homogeneous estimates of the equilibrium dissociation constants (Ka) were obtained, indicating that these agonists bind to the receptors of both tissues in an identical manner. Further, estimation of the intrinsic efficacy of agonists relative to noradrenaline, indicated no differences between the two halves of rat vas deferens. 6. Ka values for agonist activation of the functional alpha 1-adrenoceptors were compared with K, values for agonist inhibition of specific [3H]-prazosin binding. The K. values were well correlated with the low affinity K, values for phenylethylamines in both portions of rat vas deferens, suggesting that the initial event in signal transduction by alpha 1,-adrenoceptors is the binding to the low affinity state of the receptor. 7. There was a non-linear relationship between response and receptor occupancy in both halves of rat vas deferens but the occupancy-response coupling was more efficient in the epididymal than in the prostatic portion. This fact may account for the differences observed in the functional responses.

Citing Articles

Physiological and pharmacological aspects of the vas deferens-an update.

Koslov D, Andersson K Front Pharmacol. 2013; 4:101.

PMID: 23986701 PMC: 3749770. DOI: 10.3389/fphar.2013.00101.


Discrimination by SZL49 between contractions evoked by noradrenaline in longitudinal and circular muscle of human vas deferens.

Amobi N, Guillebaud J, Kaisary A, Turner E, Smith I Br J Pharmacol. 2002; 136(1):127-35.

PMID: 11976277 PMC: 1762116. DOI: 10.1038/sj.bjp.0704689.


Adrenergic and purinergic components in bisected vas deferens from spontaneously hypertensive rats.

Guitart M, Giraldo J, GONALONS E, Vila E, Badia A Br J Pharmacol. 1999; 128(4):873-80.

PMID: 10556921 PMC: 1571703. DOI: 10.1038/sj.bjp.0702845.


Study of the mechanism of the relaxant action of (+)-glaucine in rat vas deferens.

Orallo F, Fernandez Alzueta A, Loza M, Vivas N, Badia A, Campos M Br J Pharmacol. 1993; 110(3):943-8.

PMID: 8298818 PMC: 2175806. DOI: 10.1111/j.1476-5381.1993.tb13904.x.


Modulation of alpha 1-adrenoceptors and functional consequences in the bisected rat vas deferens following chronic inhibition of neuronal noradrenaline uptake.

Salles J, Badia A Br J Pharmacol. 1993; 108(3):678-83.

PMID: 8096783 PMC: 1908037. DOI: 10.1111/j.1476-5381.1993.tb12860.x.


References
1.
ARUNLAKSHANA O, SCHILD H . Some quantitative uses of drug antagonists. Br J Pharmacol Chemother. 1959; 14(1):48-58. PMC: 1481829. DOI: 10.1111/j.1476-5381.1959.tb00928.x. View

2.
WAUD D . On the measurement of the affinity of partial agonists for receptors. J Pharmacol Exp Ther. 1969; 170(1):117-22. View

3.
Ernsberger P, UPrichard D . Modulation of agonist and antagonist interactions at kidney alpha 1-adrenoceptors by nucleotides and metal ions. Eur J Pharmacol. 1987; 133(2):165-76. DOI: 10.1016/0014-2999(87)90147-6. View

4.
Marti M . Relationship between alpha-adrenoceptor occupancy and contractile response in rat vas deferens. Experimental and theoretical analysis. Eur J Pharmacol. 1988; 156(3):315-24. DOI: 10.1016/0014-2999(88)90276-2. View

5.
Morrow A, Creese I . Characterization of alpha 1-adrenergic receptor subtypes in rat brain: a reevaluation of [3H]WB4104 and [3H]prazosin binding. Mol Pharmacol. 1986; 29(4):321-30. View